Forward Features Calendar

Liquidnet expands into US equity options

Tech-driven agency execution specialist Liquidnet, has appointed Andrew Arnold as Senior Execution Trader, High Touch US Equity Options, and Jason Lichten as Senior Execution Trader, Low Touch US Equity Options to lead its news US Equity Options business.

IMF flags $4.5tn bank exposure to hedge funds and private credit

The International Monetary Fund has warned that banks in the US and Europe hold $4.5tn in exposures to hedge funds, private credit, and other non-bank financial institutions, raising concerns about systemic risk, according to a report by the Financial Times.

‘Next-gen’ macro manager MQT launches

MQT Asset Management, a next-generation macro investment manager, is gearing up to launch both funds and segregated managed accounts in early November backed with with initial investment from the firm’s partners and a seed capital provider.

Valiant leads Tiger Cub pack

Valiant Capital Management has emerged as the standout performer among Tiger Cub hedge funds in 2025, fuelled by aggressive positioning across power markets, semiconductors, and digital infrastructure, according to a report by Institutional Investor.

Ex-Morgan Stanley European Credit Head joins Point72

Gareth John, former co-head of European credit trading at Morgan Stanley, is joining Point72 in London to spearhead a new European high yield trading strategy, according to a report by eFinancial Careers citing unnamed sources familiar with the matter.

Indus Capital strengthens Japan presence with senior hire

Hedge fund Indus Capital Partners has named Makio Inui as its first Japan-based partner and head of the firm’s Tokyo office, underscoring its push to expand corporate engagement in one of Asia’s most active activist markets, according to a report

Three performance drivers could help hedge funds rev up returns

By Alex King (pictured), CFA, Investment Strategy Analyst and Adam Berger, CFA, Multi-Asset Strategist, Wellington Management – We’ve studied more than 30 years of hedge fund industry data and found that performance has tended to be strongest in periods of

Shah Capital urges Novavax sale amid ongoing underperformance

Activist hedge fund Shah Capital has called on the board of Novavax to pursue a sale, citing ongoing operational challenges and marketing missteps that have hindered the vaccine maker’s performance for a third consecutive year, according to a report by

Events

08 October, 2026 – 5:00 pm

Directory Listings

Please select one of the below *
Notify Me
Firm Type *
Please select below
Terms & Conditions *
Privacy Policy *